Controllare lo stato dell'ordine

Entra a far parte di una comunità di amanti dei libri di tutto il mondo e ottieni numerosi vantaggi. Crea un account gratuito

Punto Poste 5.49 € Punto Poste 5.49 € Corriere DHL 6.99 € Corriere GLS 5.99 € Punto GLS 4.49 € Corriere Bartolini 4.49 € Punto Bartolini 3.49 €

Contatto

Come acquistare

Aiuto

Il mio account

▸ Vuoto :-(

Adenosinergic System

Name: Adenosinergic System
Brand: Springer International Publishing AG
SKU: 09301187
Price: 136.09 EUR
Availability: InStock
Author: Micaela Morelli
ISBN: 9783319202723

A Non-Dopaminergic Target in Parkinson's Disease

Micaela Morelli

Nicola Simola

Jadwiga Wardas

Lingua

Inglese

Libro Rigido

Codice Libristo: 09301187

Casa editrice Springer International Publishing AG, settembre 2015

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease... Descrizione completa

Codice Libristo: 09301187

333 b

136.09 €

Magazzino esterno Inviamo tra 10-13 giorni

Fino a 30 giorni per il reso

I clienti hanno acquistato anche

Diář měsíční kapesní 2026 - Torino modrá

Agenda

0.89 €

La batalla de Francia 50Minutos

Adobe ePub DRM

9.49 €

alfabeto simbolico degli animali Francesco Zambon

In brossura

22.80 €

The New World Tradd Moore

Rigido

26.39 €

Měla by to být blondýnka s modrýma očima/Blondinka s golubymi glazami Anton Pavlovič Čechov

Rigido

4.09 €

Otto Placht - Sol Silvestre Otto Placht

In brossura

6.39 €

Workshop Kunst Herbert Schöttle

In brossura

37.39 €

Die Reise einer jungen Anarchistin in Griechenland. Marlene Streeruwitz

In brossura

7.99 €

Mein Mathebuch - Ausgabe B für Bayern - 3. Jahrgangsstufe Brigitte Dangelat-Bergner

In brossura

10.49 €

Verteilungsverfahren Ferdinand Wollenschläger

Rigido

134.09 €

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease, and (3) a study of urate as a possible biomarker and neuroprotectant.